Publications by authors named "Chidiebere F Uchechukwu"
Article Synopsis
- Bacteriophages are being explored as alternatives to antibiotics due to the rise of antibiotic-resistant bacterial infections.
- Clinical trials have demonstrated their effectiveness against these resistant bacteria, highlighting a need for new treatment methods.
- Future research should focus on understanding phage resistance, combining therapies with other antimicrobial agents, and overcoming delivery challenges to enhance phage therapy success.
Desmoglein-2 (DSG2) has emerged as a potential biomarker for coronavirus disease 2019 (COVID-19) complications, particularly cardiac and cardiovascular involvement. The expression of DSG2 in lung tissues has been detected at elevated levels, and circulating DSG2 levels correlate with COVID-19 severity. DSG2 may contribute to myocardial injury, cardiac dysfunction and vascular endothelial dysfunction in COVID-19.
View Article and Find Full Text PDF